Published in:
01-06-2018 | EPIDEMIOLOGY AND BURDEN OF HEADACHE
Gender and education inequalities in the cost of medication-overuse headache
Authors:
Alberto Raggi, Matilde Leonardi, Chiara Scaratti, Emanuela Sansone, Licia Grazzi, Domenico D’Amico
Published in:
Neurological Sciences
|
Special Issue 1/2018
Login to get access
Excerpt
The evaluation of the costs of headache disorders has been traditionally performed with a top-down approach by which, on the basis of pre-defined structures of cost, reasonable estimates are calculated. The most prominent example of such an approach is the EUROLIGHT project, a population study specifically aimed to address the cost of headache disorders [
1]: according to EUROLIGHT, the cost of medication-overuse headache (MOH) per patient in Europe is estimated at 3561 €/year (around 6000 €/year for Italy). However, as previously shown [
2], the assumptions used to produce the estimates do not seem to fit for those conditions characterized by high frequency, such as MOH, and these assumption have an impact on all categories cost. …
